Clinical Trial Update: Kamlanoflast In Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Kamlanoflast is being studied in amyotrophic lateral sclerosis in Phase 1/Phase 2 trials, with the study status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Kamlanoflast

Snippet

Sponsor: Inflammasome Therapeutics | Conditions: ALS (Amyotrophic Lateral Sclerosis), ALS | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING